Granted Patent
B2
US 10,696,668 · App. 16/079,162 · Granted Jun 30, 2020
Acid addition salts of piperazine derivatives
Inventors:
Anna Quattropani (Rolle, CH); Santosh S. Kulkarni (Bangalore, IN); Awadut Gajendra Giri (Bangalore, IN); Dawn V. Toronto (Saint Lamain, FR); David Malcolm Crowe (Reading, GB)
Assignee:
Asceneuron SA
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to acid addition salts of piperazine derivatives, as well as solid forms, such as polymorphic forms, thereof, which are useful as pharmaceutical ingredients and, in particular, as glycosidase inhibitors.
Claims (2)
1. N-(5-{4-[(1S)-1-(2H-1,3-benzodioxol-5-yl)ethyl]piperazin-1-yl}-1,3,4-thiadiazol-2-yl)acetamide, mono-hydrochloride in a solid form having the characteristic X-ray powder diffraction pattern as shown on FIG. 11 .
2. A solid oral dosage form comprising an acid addition salt according to claim 1 .
Assignments (3)
RELEASE OF SECURITY INTEREST
Recorded Feb 23, 2023
From: KREOS CAPITAL VI (UK) LIMITED
To: ASCENEURON SA
Reel/Frame 062789/0477 →
SECURITY INTEREST
Recorded Mar 22, 2022
From: ASCENEURON SA
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 059337/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 23, 2018
From: QUATTROPANI, ANNA; KULKARNI, SANTOSH S.; GIRI, AWADUT GAJENDRA; TORONTO, DAWN V.; CROWE, DAVID MALCOLM
To: ASCENEURON SA
Reel/Frame 047276/0072 →
Priority Claims (1)
IN 201621006638
· Feb 25, 2016
· national
Continuity (1)
Cited By (3)